Literature DB >> 18757252

Determination of betamethasone and betamethasone 17-monopropionate in human plasma by liquid chromatography-positive/negative electrospray ionization tandem mass spectrometry.

Jian-Jun Zou1, Li Dai, Li Ding, Da-Wei Xiao, Zhu-Yu Bin, Hong-Wei Fan, Li Liu, Guang-Ji Wang.   

Abstract

This study presents a high-performance liquid chromatography-positive/negative electrospray ionization tandem mass spectrometric (LC-ESI(+/-)-MS-MS) method for the determination of betamethasone (BOH) and betamethasone 17-monopropionate (B17P) in human plasma using beclomethasone dipropionate as the internal standard (I.S.). Both compounds were extracted from human plasma with ether-cyclohexane (4:1, v/v) and were separated by HPLC on a Hanbon Lichrospher C(18) column with a mobile phase of methanol-water (85:15, v/v) at a flow rate of 0.7ml/min. Calibration curves were linear over the range of 0.10-50ng/ml for BOH and 0.050-50ng/ml for B17P. The inter-run relative standard deviations were less than 14.4% for BOH and 12.3% for B17P. The intra-run relative standard deviations were less than 9.3% for BOH and 7.9% for B17P. The mean plasma extraction recovery for BOH and B17P were in the ranges of 82.7-85.9% and 83.6-85.3%, respectively. The method was successfully applied to study the pharmacokinetics of a new formulation of betamethasone phosphate/betamethasone dipropionate injection in healthy Chinese volunteers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757252     DOI: 10.1016/j.jchromb.2008.08.011

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Quantitative determination of betamethasone sodium phosphate and betamethasone dipropionate in human plasma by UPLC-MS/MS and a bioequivalence study.

Authors:  Man-Yun Chen; Yong-Jun Tang; Yi-Cheng Wang; Chong-Zhi Wang; Chun-Su Yuan; Yao Chen; Zhi-Rong Tan; Wei-Hua Huang; Hong-Hao Zhou
Journal:  Anal Methods       Date:  2016-03-29       Impact factor: 2.896

2.  Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension.

Authors:  Alice Simon; Vinícius Raphael de Almeida Borges; Lucio Mendes Cabral; Valéria Pereira de Sousa
Journal:  AAPS PharmSciTech       Date:  2013-02-01       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.